Danaher's Q4 2024 Revenue Boosted by Life Sciences and Biotech Growth

Washington, D.C., Thursday, 30 January 2025.
Danaher Corporation reports a 2% rise in 4Q revenue to $6.54 billion, fueled by significant gains in life sciences and biotechnology, despite forecasting a slight revenue decline for next quarter.